Aker BioMarine

Report Publication Announcement • Mar 31, 2025

Aker BioMarine ASA – Annual Report 2024

Aker BioMarine ASA – Annual Report 2024

31 March 2025: Aker BioMarine ASA today publishes its Annual Report for 2024, which includes the annual accounts, the sustainability statement and the auditor's report for 2024.

The report is attached and is also available at www.akerbiomarine.com.

Aker BioMarine ASA has also published its annual financial statements in European

Single Electronic Format (ESEF), available as an attachment to this release.

For further information, please contact

Christopher Robin Vinter, VP Strategic Finance & IR

Mobile: +47 911 60 820

Email: Christopher.vinter@akerbiomarine.com

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.

About Aker BioMarine

Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, FloraMarine, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION (reduce and recycle plastic waste across industries) and Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.